NH Foods recently raised its full-year consolidated earnings guidance for the period ending March 31, 2026, citing an expected increase in net sales to ¥1.43 trillion and profit attributable to owners to ¥34 billion, driven by strength in its Fresh Meats Business.
This upward revision reflects higher domestic chicken prices and strong demand for Australian beef, supporting improved operational performance in key product lines.
With production increases in Australian beef highlighted in the...
Santen Pharmaceutical (TSE:4536) just received approval from the UK medicines regulator for its new pediatric myopia treatment, Ryjunea. This move strengthens the company’s footprint in Europe and signals a growing opportunity in children’s eye health.
See our latest analysis for Santen Pharmaceutical.
Santen Pharmaceutical’s shares have shown fresh momentum lately, helped by regulatory wins and a sizable buyback program that wrapped up just last week. While the stock’s year-to-date price...
On November 7, 2025, Osaka Soda Co., Ltd. announced board approval for a share repurchase program, aiming to buy back 5,000,000 shares, about 3.99% of its outstanding shares, for ¥5,000 million by January 30, 2026.
This move highlights the company's priority to enhance shareholder returns and capital efficiency, reflecting management's confidence in its outlook.
We'll explore how Osaka Soda's significant buyback initiative shapes its investment narrative and what this means for shareholder...
Hino Motors announced on November 4, 2025, an upward revision to its consolidated earnings guidance for the fiscal year ending March 31, 2026, alongside the appointment of Satyakam Arya as the company’s new President, effective April 2026.
The improved outlook reflects anticipated increases in operating income and profit, partly driven by shifts in vehicle production for Toyota and evolving truck and bus sales trends.
We will explore how the enhanced profit forecast, with a focus on higher...
